Myris Therapeutics
  • HOME
  • COMPANY
    • ABOUT
    • OUR TEAM
    • SCIENTIFIC PUBLICATIONS
  • NEWS
  • CONTACT
Select Page

1983

by Jason Anthony | Nov 27, 2019 | timeline

Ed Merrill identifies Polyethylene Oxide as a Biomaterial

1981

by Jason Anthony | Nov 25, 2019 | timeline

Enzon founded

1968

by Jason Anthony | Nov 25, 2019 | timeline

Frank Davis proposes protein-polymer conjugates

BioHybrid Solutions™ named one of the 40 “Best University Startups 2017”

by Jason Anthony | Apr 13, 2017 | News

BioHybrid Solutions™ has been named one of the 40 “Best University Startups 2017” by the National Council of Entrepreneurial Tech Transfer. Antonina Simakova, Ph.D., BHS Director of Research and Development, will present at the University Startups...

Harmar startup sees potential in tech that could turn paint into toxin detector

by Jason Anthony | Nov 8, 2016 | News

Technology that could help create paint that can alert people to the presence of a toxin or packaging that changes color with the expiration date of the food inside clearly has potential on the commercial market. And now two long-time collaborators from Carnegie...
« Older Entries
Next Entries »

Recent Posts

  • Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
  • BioHybrid Solutions Holdings, Inc. Announces Expansion of its Drug Development Leadership  
  • BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member
  • BioHybrid Solutions™ announces the formation of its Holdings Corporation and Subsidiaries
  • BioHybrid Solutions™ Announces Jean Pineault as President and Chief Executive Officer

Recent Comments

    Archives

    • February 2025
    • June 2023
    • September 2022
    • May 2022
    • January 2022
    • December 2019
    • November 2019
    • April 2017
    • November 2016
    • October 2016
    Copyright © Myris Therapeutics